CER Daily Newsfeed

New Research Highlight Shines Spotlight on PCORnet® Studies to Improve the Health and Healthcare of Children

(12/18, PCORnet Blog) comments “...The research highlight provides an overview of pediatric PCORnet® Studies that are generating real-world evidence to help patients and their caregivers make healthier choices and more informed healthcare decisions. The Pediatric PCORnet® Population Insights Report provides researchers with details about the capacity of the infrastructure of PCORnet to support national-scale pediatric research across a range of common and rare health conditions.” Full

CMS’ ACCESS Model: A New Push to Rewire Medicare Around Outcomes?

(12/18, Katie Adams, MedCity News) reports “...Experts think it is CMS’ clearest attempt yet to move traditional Medicare fee-for-service toward an outcomes model, as well as a key effort to help expand care beyond the four walls of a hospital or clinic. However, they provide a caveat: the success of ACCESS will depend on sustained participation, clear metrics and the ability to integrate data and digital tools across fragmented care settings.” Full

340B Transparency Requirements Will Begin Restraining Spending Growth in 2026

(12/17, Cathy Kelly, Pink Sheet) ...[Drug Channels Institute President Adam Fein] said the rate of 2026 spending at 340B prices will slow significantly relative to current trends and total $96bn, or 16.9% above 2024. ‘The Inflation Reduction Act is going to force transparency into the 340B program,’ he said. ‘In fact, I suspect the hospital associations and others [representing 340B covered entities] who were big advocates of the IRA are probably regretting their lobbying dollars right now.’” Subscription Required

Accelerating HTA Readiness with Generative AI

(12/17, Angeline Dhas, PharmTech) comments “...Once an industry player demonstrates a significant time- and efficiency-advantage in the regulatory path to patient access, the bar is raised for everyone else. Likewise, as GenAI becomes more accepted, HTAs will require faster evidence synthesis with ever more robust validation capabilities. More transparent justification of value will also be necessary as the technology is tested with projects of greater complexity.” Full